Metastasis and Heart attack
Summary:
Heart attack is found among people with Metastasis, especially for people who are male, 60+ old.
The study analyzes which people have Heart attack with Metastasis. It is created by eHealthMe based on reports of 19 people who have Metastasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Metastasis?
Metastasis (spreadable cancer to other organ from origin) is found to be associated with 537 drugs and 842 conditions by eHealthMe. Check the latest studies of Metastasis.
What is Heart attack?
Heart attack is found to be associated with 2,479 drugs and 3,298 conditions by eHealthMe. Check the latest studies of Heart attack.
19 people who have Metastasis and Heart Attack are studied.

Gender of people who have Metastasis and experienced Heart Attack *:
- female: 10.53 %
- male: 89.47 %
Age of people who have Metastasis and experienced Heart Attack *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.76 %
- 50-59: 5.88 %
- 60+: 82.35 %
Common co-existing conditions for these people *:
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 4 people, 21.05%
- Renal Cancer Metastatic (cancer of kidney spreads to other part): 2 people, 10.53%
- High Blood Pressure: 2 people, 10.53%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
- Prostate Cancer Metastatic: 1 person, 5.26%
- Prostate Cancer: 1 person, 5.26%
- Pain: 1 person, 5.26%
- Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 5.26%
- High Blood Cholesterol: 1 person, 5.26%
- Depression: 1 person, 5.26%
Common drugs taken by these people *:
- Sutent: 6 people, 31.58%
- Zometa: 3 people, 15.79%
- Cisplatin: 3 people, 15.79%
- Amlodipine: 2 people, 10.53%
- Aspirin: 2 people, 10.53%
- Omeprazole: 2 people, 10.53%
- Firmagon: 1 person, 5.26%
- Hydrochlorothiazide: 1 person, 5.26%
- Gleevec: 1 person, 5.26%
- Gemzar: 1 person, 5.26%
Common symptoms for these people *:
- Cardiac Arrest: 5 people, 26.32%
- Electrocardiogram St Segment Elevation: 3 people, 15.79%
- Chest Pain: 3 people, 15.79%
- Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 3 people, 15.79%
- Ventricular Fibrillation (abnormally irregular heart rhythm): 3 people, 15.79%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 15.79%
- Acute Kidney Failure: 3 people, 15.79%
- Weakness: 3 people, 15.79%
- Dyspnea (difficult or laboured breathing): 2 people, 10.53%
- Hypotension (abnormally low blood pressure): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Heart attack?
- Check whether Heart attack is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Metastasis (11,222 reports)
- Heart attack (266,145 reports)
All the drugs that are associated with Heart attack:
- Heart attack (2,479 drugs)
All the conditions that are associated with Heart attack:
- Heart attack (3,298 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Heart attack and Metastasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amylase Increased and drugs of ingredients of linezolid - 6 seconds ago
- Could Glyburide cause Presyncope? - 16 seconds ago
- Drug interactions of Tenormin and Tradjenta - 19 seconds ago
- Could Oxaliplatin cause Hypogammaglobulinaemia? - 36 seconds ago
- Could Guaifenesin cause Therapeutic Response Decreased? - 38 seconds ago
- Keytruda and Stomachache for Women aged 50-59 - 53 seconds ago
- Keytruda and Stomach Pain for Women aged 50-59 - 54 seconds ago
- Keytruda and Pain - Abdomen for Women aged 50-59 - 54 seconds ago
- Keytruda and Belly Ache for Women aged 50-59 - 54 seconds ago
- Keytruda and Abdominal Cramps for Women aged 50-59 - 54 seconds ago